In Vitro Model to Test Therapeutic Agents Against Rhinovirus Infection

Area of Science:

• Virology
• Cell Biology
• Drug Discovery

Background:

• Rhinoviruses infect airway epithelial cells, but replication is limited, hindering drug development.
• Cytokine production (interferons, CXCL-10) serves as a surrogate for rhinovirus load in cell culture.
• A robust cell culture model is crucial for antiviral drug screening.

Purpose of the Study:

• To establish and validate a cell culture method for studying rhinovirus infection.
• To utilize cytokine production as a measurable indicator of viral activity.
• To provide a platform for screening antiviral compounds targeting rhinovirus.

Main Methods:

• Utilized the immortalized human bronchial epithelial cell line BEAS-2B.
• Infected BEAS-2B cells with rhinovirus A and B in serum-free medium.
• Measured virus-induced cytokine production (CXCL-8 and CXCL-10) using ELISA.

Main Results:

• BEAS-2B cells support rhinovirus A and B infection.
• Viral binding, endocytosis, and replication induce CXCL-8 production.
• Replicating rhinovirus robustly stimulates CXCL-10 production in BEAS-2B cells.
• CXCL-8 and CXCL-10 are readily quantifiable via ELISA.

Conclusions:

• The BEAS-2B cell culture system provides a reliable model for rhinovirus infection studies.
• This method allows for the assessment of antiviral drugs inhibiting rhinovirus binding, endocytosis, and replication.
• The cytokine-based assay facilitates efficient screening of potential antiviral therapeutics.